Our research

Detect Early. Treat better. Save lives.

Decades of underfunding mean that we still lack the tests and treatments to tackle this brutal disease. Hope alone can’t fix this. People with pancreatic cancer need action now.

That’s why our research strategy is vitally important. It aims to transform the future for people with pancreatic cancer. From cutting-edge tests to cancer-killing therapies, our scientists are striving for earlier detection and better treatment.

We’re also investing in the brightest minds, to grow the research community and accelerate the life-saving breakthroughs that we so urgently need.

Early detection

Late diagnosis is one of the biggest issues in pancreatic cancer but we’re investing in ground-breaking research to change this.

Find out more
Scientist pipetting with hands in a laboratory

Improving treatment and care

As well as investing in research to save lives, we’re also working to transform people’s experience of pancreatic cancer, funding new approaches and encouraging innovative thinking.

Find out more
Hospital appointment
Two researchers working together in a lab wearing their white lab coats

Our research strategy

Our strategy lays out how we will work with world leading researchers and with people affected by pancreatic cancer, to fund research that will transform and save lives.

Find out more
Dr Shalini Rao and Professon Jason Carroll

Building research capacity

Researchers will find the breakthroughs needed in pancreatic cancer, so we must do everything we can to build and support the community.

Find out more

Are you a researcher?

Find out more about opportunities for funding and support for the pancreatic cancer research community. Together we are the research community taking pancreatic cancer on.

Read more
  • Insights from people newly diagnosed

    Insights from people newly diagnosed

    We welcome the commitment in the National Cancer Plan to establish direct referral pathways over the coming years, ensuring that people newly diagnose...

  • Just 12% of pancreatic cancer patients given the chance to join a clinical trial

    Just 12% of pancreatic cancer patients given the chance to join a clinical trial

    Only 12% of people with pancreatic cancer are given the chance to take part in a clinical trial, emphasising the lack of progress in developing treatm...

  • We’re demanding treatment breakthroughs. We’re demanding survival.

    We’re demanding treatment breakthroughs. We’re demanding survival.

    Today marks the launch of our Demand Survival Now petition, calling on governments across the UK to fund more research for treatment breakthroughs